Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
72
datasets available to search
ShareScore release 0.9.0
Dataset results
72 results for “primary myelofibrosis”
Asian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MF
ClinicalTrials.gov study NCT01392443. IPD Sharing: UNDECIDED. Countries: 4. Publications: 1.
Role of Myeloid-derived Suppressor Cells In Primary Myelofibrosis
ClinicalTrials.gov study NCT07319026. IPD Sharing: NO. Countries: 1. Publications: 8.
Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF
ClinicalTrials.gov study NCT02101268. IPD Sharing: Not stated. Countries: 8. Publications: 5.
Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)
ClinicalTrials.gov study NCT02515630. IPD Sharing: Not stated. Countries: 2. Publications: 1.
An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-esse
ClinicalTrials.gov study NCT03952039. IPD Sharing: YES. Countries: 16. Publications: 1.
Ruxolitinib (INCB018424) in Participants With Primary Myelofibrosis (PMF), Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis (PPV-MF)
ClinicalTrials.gov study NCT01348490. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis
ClinicalTrials.gov study NCT01731951. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF
ClinicalTrials.gov study NCT01423851. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Trea
ClinicalTrials.gov study NCT03755518. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myel
ClinicalTrials.gov study NCT04884191. IPD Sharing: Not stated. Countries: 8. Publications: 1.
LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis
ClinicalTrials.gov study NCT02098161. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (
ClinicalTrials.gov study NCT01317875. IPD Sharing: NO. Countries: 8. Publications: 1.
INC424 for Patients With Primary Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis.
ClinicalTrials.gov study NCT01493414. IPD Sharing: UNDECIDED. Countries: 25. Publications: 4.
A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis
ClinicalTrials.gov study NCT00931762. IPD Sharing: Not stated. Countries: 1. Publications: 1.
To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Mo
ClinicalTrials.gov study NCT04629508. IPD Sharing: YES. Countries: 7. Publications: 0.
Safety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis
ClinicalTrials.gov study NCT01423058. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)
ClinicalTrials.gov study NCT00935987. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells
ClinicalTrials.gov study NCT06896344. IPD Sharing: NO. Countries: 1. Publications: 2.
Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis
ClinicalTrials.gov study NCT05535764. IPD Sharing: NO. Countries: 1. Publications: 0.
18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia
ClinicalTrials.gov study NCT03116542. IPD Sharing: NO. Countries: 1. Publications: 14.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.